GMM Pfaudler (505255) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
10 Aug, 2026Executive summary
Completed a major organizational transformation, shifting from regional to four global technology divisions (CRT, PPT, HET, PST) with dedicated leadership and accountability for technology, product, and customer engagement.
Revenue grew 16% year-over-year to ₹925 crore, with EBITDA at ₹94 crore (down 7% YoY), and PAT at ₹23.90 crore (up over 100% YoY).
Order intake reached ₹1,007 crore, flat YoY but up 16% QoQ, and backlog increased 20% YoY to ₹2,289 crore.
Leadership team strengthened, with clear roles and succession planning to drive global mindset and performance alignment.
Major orders secured in mining and petrochemical sectors, strengthening diversification.
Financial highlights
Consolidated revenue for Q1 FY 2027 was ₹924.76 crore, up 16% year-on-year.
EBITDA stood at ₹94 crore, down 7% YoY but up 25% sequentially; EBITDA margin was 10.1%, down from 12.7% YoY but up from 8.0% sequentially.
Profit After Tax was ₹23.90 crore, more than doubling year-on-year; PAT margin improved to 2.4% from 1.3% YoY.
Basic EPS rose 114% YoY to ₹5.32.
Order backlog reached ₹2,289 crore, up 20% YoY and 4% QoQ, with most orders executable within FY 2027.
Outlook and guidance
Management targets a minimum 15% EBITDA margin over the medium term, with ongoing initiatives to improve margins and cost structure.
Margin improvement expected as underperforming units are addressed and integration synergies are realized.
Positive momentum expected to continue, supported by a healthy order pipeline and strong backlog.
Ongoing initiatives to reduce debt and optimize capital structure, with EUR 7 million debt repayment planned by Q2 FY27.
Strong revenue visibility for FY 2027 due to robust order backlog and improving market conditions, especially in pharma.
Latest events from GMM Pfaudler
- Double-digit revenue and EBITDA growth, record order intake, and a ₹2 per share dividend announced.505255
Q4 25/26 - Record order backlog and margin initiatives drive growth despite one-time costs.505255
Q3 25/26 - Q2 FY26 saw strong growth, record backlog, and global expansion with key acquisitions.505255
Q2 25/26 - Strong EBITDA growth, robust order intake, and SEMCO acquisition drive global expansion.505255
Q1 25/26 - Q2 FY25 saw strong overseas-driven growth, robust backlog, and a ₹1 interim dividend.505255
Q2 24/25 - Record order intake and stable revenue offset margin and profit declines; 5%-10% growth targeted.505255
Q1 24/25 - Resilient growth, diversification, and strategic expansion drive optimism amid sector headwinds.505255
AGM 2024 - Revenue down, profit hit by one-time costs, but cash flow and leverage improved.505255
Q4 24/25 - Q3 FY25 saw stable revenue, margin gains, and strong overseas-driven profit growth.505255
Q3 24/25